Navigation Links
Cord Blood America Announces Second Supply Agreement to Provide Placenta, Umbilical Cord Collection Services to Major Tissue Bank
Date:2/4/2011

LAS VEGAS, Feb. 4, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has signed a Supply Agreement with a premier national and international cell and tissue bank to provide placenta, umbilical cord blood and whole umbilical cord collection services for research purposes.

The cell and tissue bank is well known for its patented success developing procedures to store unique cell and tissue types.  "The research it undertakes is important to secure the future of stem cell therapy," said Matthew Schissler, Cord Blood America co-founder and CEO. "Research is highly confidential and highly competitive at the same time, so confidentiality of the party is a must."

"This is the second supply agreement we have signed.  These are important transactions that allow Cord Blood America to diversify its revenue stream.  The first agreement, announced in April 2010, provided approximately five percent of our revenues in the third quarter of 2010, showing the importance of these agreements with world renowned entities."

The placenta (sometimes called afterbirth) connects the developing fetus to the uterine wall and supplies oxygen and food.  Research has shown there are a significant number of stem cells in the placenta.  The umbilical cord is the connecting cord between the embryo and the placenta and cord blood also contains medical useful stem cells.  Until recent years, all this was disposed as medical waste.

About Cord Blood AmericaCord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.CONTACT:Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
3. Limbs saved by menstrual blood stem cells
4. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
5. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
6. No Blood Needed Thanks to Innovative Medical Technology
7. The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
8. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
9. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
10. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
11. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... ... 2017 , ... Sonic Manufacturing Technologies is proud to be ... solar system on its roof top. “We will be independent of the grid ... stated. The company’s proud history of social responsibility and participation in the preservation ...
(Date:7/14/2017)... ... July 13, 2017 , ... ... verification test kit has received US FDA 510 (k) clearance for use on ... matrix, evaluates D-Dimer. Each VALIDATE® D-Dimer kit, prepared using the CLSI EP06-A “equal ...
(Date:7/13/2017)... ... ... Thousands of pilots from across the country will visit the AMA’s International ... to Muncie to compete in various categories of model flying competition. Each pilot comes ... championships. , RC Pylon (July 14-21): One of the most fun competitions to watch! ...
(Date:7/13/2017)... ... 2017 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), the ... of a major transaction with Eurazeo PME. The reputable French private equity comes ... In’Tech Medical’s service offerings while leveraging the company’s manufacturing expertise and global footprint. ...
Breaking Biology Technology:
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):